Yıl: 2021 Cilt: 5 Sayı: 1 Sayfa Aralığı: 51 - 55 Metin Dili: Türkçe İndeks Tarihi: 16-06-2021

Sarkoidoz ve Göz Tutulumu

Öz:
Sarkoidoz histopatolojik düzeyde non-kazeifiyegranülomlarla karakterize enflamatuar sistemik bir hastalıktır. Okulersarkoidozunun çok çeşitli belirtileri ve bulguları vardır. Günümüzde hala sarkoidozun tanısı, özellikle ekstrapulmoner tutulumlarda bir sorun olmaya devam etmektedir. Göz tutulumunda anatomik tutulum yeri ve inflamasyonun ciddiyetine bağlı olarak tedavide, yerel ve/veya sistemik kortikosteroid ile immünomodülatörler kullanılır. Gelecekte, sarkoidoz tanısında özgün genlerden yararlanılacak ve mikrobiyolojik gelişmelerde hastalığın bulaşıcı etyolojisini açığa çıkarabilecektir. Bunlarda sarkoidozun tedavi yaklaşımlarını değiştirebilecektir.
Anahtar Kelime:

Sarcoidosis and Ocular Involvement

Öz:
Sarcoidosis is an inflammatory systemic disease characterized by non-caseifying granulomas at histopathological level.Ocular sarcoidosis has many symptoms and signs.Currently, the diagnosis of sarcoidosis remains a problem, especially inextrapulmonary involvement. Local and / or systemic corticosteroids and immunomodulators are used in the treatmentdepending on the location of the anatomical involvement in the eye and the severity of inflammation.In the future, specificgenes will be utilized in the diagnosis of sarcoidosis and will be able to reveal its infectious etiology in microbiological deve lopments. And these developments will be able to change the treatment approaches of sarcoidosis.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik
  • 1. Young RC Jr, Rachal RE, Cowan CL Jr. Sarcoidosis – The Beginning: Historical Highlights of Personalities and Their Accomplishments During the Early Years. J Nalt Med Assoc. 1984; 76(9): 887-896.
  • 2. Heerfordt CF. On febris uveo parotidea subchronica localized in the parotid gland and uvea of the eye, frequently complicated by paralysis of the cerebrospinal nerves. Ugeskr Laeger.1909;71:417-421
  • 3. Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V, Baretton G. Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis. 2005; 22(1): 66-74
  • 4. Grosser M, Luther T, Muller L, SchupPler M,Bickhardt J,Matthiessen W ,et al. Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. Lab Invest. 1999; 79(7): 775-84.
  • 5. Crystal RG. Sarcoidosis. In: Fauci AS, Isselbacher KJ, Braunwald E, et al, eds. Harrison’s Principles of Internal Medicine. 14th ed. McGraw-Hill; 1998:1922-8.
  • 6. Birnbaum AD, Oh FS, Chakrabarti A, Tessler HH, Goldstein DA. Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol. 2011;129(4):409-13
  • 7. Herbort CP, Rao NA, Mochizuki M, members of Scientific Committee of First International Workshop on Ocular Sarcoidosis, Bodaghi B, Baarsma SG, Chee SP et al. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009; 17(3):160-9.
  • 8. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol .2000;84(1):110–116
  • 9. Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):452–462
  • 10. Akyol N, Türk A, Alioğlu Z, Sözen E, İmamoğlu Hİ. Bilateral Panüveitis in neurosarcoidosis with spinal cord involvement. Asian J Opthalmol.2006:8(5):208-10
  • 11. Heuser K, Kerty E. Neuro-ophthalmological findings in sarcoidosis. Acta Ophthalmol Scand.2004;82(6):723-9
  • 12. Spalton DJ, Sanders MD. Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol. 1981; 65(5): 348-58.
  • 13. Koonitz CH, Joyner LR, Nelson RA. Trans bronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med. 1976 ; 85(1): 64- 6.
  • 14. Akyol N, Türk A, Kola M, Erdöl H, Mungan S. Sarkoidozda görülen göz bulgularının Ultrasonik Biomikroskopi ve Optik KoherensTomografi ile Değerlendirilmesi. Turkiye Klinikleri J Ophthalmol. 2008;17(3):219-22
  • 15. Nosal A, Schleissner LA, Mishkin FS, Lieberman J. Angiotensin-I-converting enzyme and gallium scan in noninvasive evaluation of sarcoidosis. Ann Intern Med.1979; 90(3): 328-31.
  • 16. Baarsma GS, La Hey E, Glasius E ,de Vries J, Kijlstra A. The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol.1987;104(3):211-7
  • 17. Kogure M. Treatment of ocular manifestations of sarcoidosis. Nippon Rinsho. 1994; 52(6): 1654-8.
  • 18. Controlled evaluation of loteprendnol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol etabonate US uveitis study. Am J Ophthalmol. 1999; 127(5): 537–544
  • 19. Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA; Multicenter Uveitis Steroid Treatment Trial Research Group. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol.2010;149(4):550–561.
  • 20. Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment forsarcoid-associated panuveitis. Ophthalmology. 1999;106(1):111–118
  • 21. Galor A, Jabs DA, Leder HA,Kedhar SR,Dunn JP,Peters GB 3rd, et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology.2008; 115(10): 1826–1832
  • 22. Müller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/ prednisolone regimen. Eur Respir J. 1999;14(5):1117–1122
  • 23. Akova AY, Kadayıfçılar S, Aydın P. Sarkoidoz. Retina Vitreus. 2000; 8(1): 102-113.
  • 24. Mirza GE: İnflamatuar Glokom. Glokom-Katarakt. 2011;6(1): 60-63.
  • 25. Herbert HM, Heather J, Lightmann SL. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004;13(2):96-99.
  • 26. Panek WC, Holland GN, Lee DA, Christensen RE. Glaucoma in patients with uveitis. Br J Ophthalmol 1990; 74(4): 223-227.
APA Akyol N, Uzlu D, KÖSE B (2021). Sarkoidoz ve Göz Tutulumu. , 51 - 55.
Chicago Akyol Nurettin,Uzlu Dilek,KÖSE BÜŞRA Sarkoidoz ve Göz Tutulumu. (2021): 51 - 55.
MLA Akyol Nurettin,Uzlu Dilek,KÖSE BÜŞRA Sarkoidoz ve Göz Tutulumu. , 2021, ss.51 - 55.
AMA Akyol N,Uzlu D,KÖSE B Sarkoidoz ve Göz Tutulumu. . 2021; 51 - 55.
Vancouver Akyol N,Uzlu D,KÖSE B Sarkoidoz ve Göz Tutulumu. . 2021; 51 - 55.
IEEE Akyol N,Uzlu D,KÖSE B "Sarkoidoz ve Göz Tutulumu." , ss.51 - 55, 2021.
ISNAD Akyol, Nurettin vd. "Sarkoidoz ve Göz Tutulumu". (2021), 51-55.
APA Akyol N, Uzlu D, KÖSE B (2021). Sarkoidoz ve Göz Tutulumu. Güncel Retina Dergisi, 5(1), 51 - 55.
Chicago Akyol Nurettin,Uzlu Dilek,KÖSE BÜŞRA Sarkoidoz ve Göz Tutulumu. Güncel Retina Dergisi 5, no.1 (2021): 51 - 55.
MLA Akyol Nurettin,Uzlu Dilek,KÖSE BÜŞRA Sarkoidoz ve Göz Tutulumu. Güncel Retina Dergisi, vol.5, no.1, 2021, ss.51 - 55.
AMA Akyol N,Uzlu D,KÖSE B Sarkoidoz ve Göz Tutulumu. Güncel Retina Dergisi. 2021; 5(1): 51 - 55.
Vancouver Akyol N,Uzlu D,KÖSE B Sarkoidoz ve Göz Tutulumu. Güncel Retina Dergisi. 2021; 5(1): 51 - 55.
IEEE Akyol N,Uzlu D,KÖSE B "Sarkoidoz ve Göz Tutulumu." Güncel Retina Dergisi, 5, ss.51 - 55, 2021.
ISNAD Akyol, Nurettin vd. "Sarkoidoz ve Göz Tutulumu". Güncel Retina Dergisi 5/1 (2021), 51-55.